NEW YORK (GenomeWeb News) — The Wistar Institute and the University of the Sciences, both located in Philadelphia, today unveiled a new Molecular Screening Facility at the institute, which is part of a larger medical research partnership between them that will seek new compounds for potential therapies.
 
The $1.1 million screening facility and the Center for Chemical Biology and Translational Medicine combines Wistar’s biomedical research capabilities with the University of Sciences’ chemical and pharmacological expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.